Recent Posts
- Eli Lilly’s Omvoh (mirikizumab) beats J&J’s Stelara in head-to-head study
- Current research opportunity on IBD and LGB people in the UK
- A potential non-invasive stool test and novel therapy for endometriosis
- Early exposure to antibiotics decreases risk of developing crohn’s disease.
- Faulty ‘fight or flight’ response drives deadly C. difficile infections, research reveals
Recent Comments
No comments to show.